Birgitta Dietz, MD, PHD
Dr.
AbbVie Deutschland GmbH & Co. KG
Knollstrasse
Ludwigshafen
Germany
67061
Papers:
BUDGET IMPACT ANALYSIS FOR THE TREATMENT OF GENOTYPE 1 CHRONIC HEPATITIS C IN GERMANY WITH OMBITASVIR / PARITAPREVIR / RITONAVIR AND DASABUVIR